Filing Details
Microbot Medical Inc. (NASDAQ:MBOT) filed its quarterly report (Form 10-Q) with the Securities and Exchange Commission on August 11, 2026.
The Healthcare company reported Q0 revenue of .
10q filedNASDAQ:MBOT
Microbot Medical Inc. (MBOT) Files Quarterly Report for Q0
Microbot Medical Inc. (NASDAQ:MBOT) filed its quarterly report (Form 10-Q) with the Securities and Exchange Commission on August 11, 2026.
At publication ·
What changed
Microbot Medical Inc. (NASDAQ:MBOT) · 10q filed
- Form
- 10-Q
At a glance
Key takeaways
- Microbot Medical Inc. filed its quarterly report (Form 10-Q) with the SEC on August 11, 2026, providing unaudited financial statements and management commentary on recent performance.
- The company's stock trades at $1.68 with a market capitalization of $108.7 million as of the filing date.
- The 10-Q filing contains timely information about emerging trends, updated risk factors, and changes in business conditions since the last annual filing.
Market Context
Microbot Medical Inc.'s stock currently trades at $1.68 with a market capitalization of $108.7M.
The 10-Q provides Microbot Medical Inc.'s quarterly financial update, including unaudited financial statements and management commentary on recent performance. While less detailed than the annual 10-K, the 10-Q often contains timely information about emerging trends, updated risk factors, and changes in business conditions since the last filing.
All SEC filings for Microbot Medical Inc. are publicly available through the SEC's EDGAR database. Investors can set up alerts for new filings to stay current on material developments.
Related Tools: View MBOT Stock Page
Frequently Asked Questions
Where can I read MBOT's SEC filings?
Browse all filings on our MBOT SEC filings page.
What types of SEC filings does Microbot Medical Inc. file?
Public companies like Microbot Medical Inc. file annual reports (10-K), quarterly reports (10-Q), material events (8-K), and insider transactions (Form 4) with the SEC.